RxDoctor Payments Data

Chad Brady

Podiatrist · Albuquerque, NMNPI 1891705794

Payments from drug & device makers

What this record shows

Paragon 28, Inc. accounts for 60.7% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2024 at $1,141 and has fallen 87.0% since, to $148 in 2025.

$2,042in general payments, 2019–2025

Across 31 payments — averaging $65.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Paragon 28, Inc.$1K
  • Stryker$581
  • Zimmer Biomet$79
  • Exactech, Inc.$62
  • Nvision Biomedical Technologies, Inc.$27
  • Smith+Nephew$15
  • plus $38 from 3 others

What the payments were for

  • Travel & lodging$83041%
  • Food & beverage$1,21259%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,042 in reported general payments places this provider in the 60th percentile of 46 podiatrist providers in New Mexico.

See all podiatrist providers in New Mexico

Medicare billing

Part B allowed, 2024
$58,792
Medicare patients
186
Services billed
585

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen32$316
Meloxicam36$222
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen11$147
Cephalexin18$134
Mupirocin12$100

Paid to pharmacies, not to this prescriber.

Other podiatrist in Albuquerque

See the full list for New Mexico

Where these figures come from

Is this you, or does something look wrong? →